Curis
CRIS
#11076
Rank
ยฃ3.46 M
Marketcap
ยฃ0.52
Share price
-23.04%
Change (1 day)
-47.93%
Change (1 year)

Earnings for Curis (CRIS)

Earnings in 2026 (TTM): -ยฃ6.55 Million

According to Curis's latest financial reports the company's current earnings are ยฃ4.31 Million. In 2025 the company made an earning of -ยฃ4.02 Million, an increase over its 2024 earnings that were of -ยฃ31.83 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Curis from 2001 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ6.55 Million63.06%
2025 -ยฃ4.02 Million-87.38%
2024 -ยฃ31.83 Million-5.77%
2023 -ยฃ33.78 Million-13.1%
2022 -ยฃ38.87 Million27.52%
2021 -ยฃ30.48 Million65.09%
2020 -ยฃ18.47 Million-9.1%
2019 -ยฃ20.31 Million-4.73%
2018 -ยฃ21.32 Million-41.95%
2017 -ยฃ36.72 Million-14.37%
2016 -ยฃ42.89 Million3.55%
2015 -ยฃ41.41 Million271.52%
2014 -ยฃ11.15 Million76.64%
2013 -ยฃ6.31 Million
2011 -ยฃ5.36 Million27.76%
2010 -ยฃ4.2 Million-43.87%
2009 -ยฃ7.48 Million-23.44%
2008 -ยฃ9.77 Million56.66%
2007 -ยฃ6.24 Million-16.71%
2006 -ยฃ7.49 Million-36.92%
2005 -ยฃ11.86 Million156.25%
2004 -ยฃ4.63 Million-37.24%
2003 -ยฃ7.38 Million-93.34%
2002 -ยฃ0.12 Billion86.79%
2001 -ยฃ59.28 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
ยฃ5.13 B-81,859.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ8.43 B-134,238.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-ยฃ46.05 Million 632.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
ยฃ0.79 B-12,716.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-ยฃ0.25 Billion 3,756.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-ยฃ16.57 Million 163.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-ยฃ70.76 Million 1,025.71%๐Ÿ‡บ๐Ÿ‡ธ USA